Full name
"CROS CRO" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.19.Z - Scientific research and development activities
46.46.Z - Wholesale trade of pharmaceutical and medical products
70.10.Z - Head office activities
70.21.Z - Head office activities and management consultancy
70.22.Z - Head office activities and management consultancy
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
78.10.Z - Employment placement and recruitment services
82.30.Z - Activities related to organizing fairs, exhibitions, and congresses
85.60.Z - Educational support activities
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -1 | 0,6 | 2,8 | 406,6 |
EBITDA | -1 | 1 | 2,9 | 194,8 |
Short time liabilities | 2,5 | 2 | 4,2 | 105,7 |
Equity capital | -0,7 | -0,2 | 2,1 | 1269,8 |
Operating profit (EBIT) | -1 | 1 | 2,9 | 194,7 |
Assets | 2,2 | 2,1 | 6,3 | 202,1 |
Net profit (loss) | -1 | 0,5 | 2,2 | 321 |
Cash | 0,8 | 0,6 | 3,4 | 440 |
Net income from sale | 4,2 | 5 | 12,7 | 152,4 |
Liabilities and provisions for liabilities | 2,9 | 2,3 | 4,2 | 86,8 |
Working assets | 1,4 | 1,1 | 4,7 | 327,4 |
Depreciation | 0 | 0 | 0 | 212,7 |
% | % | % | p.p. | |
Profitability of capital | 146,8 | -301,6 | 108,5 | 410,1 |
Equity capital to total assets | -32,1 | -8,5 | 32,9 | 41,4 |
Gross profit margin | -24,6 | 11 | 22,1 | 11,1 |
EBITDA Margin | -24 | 19,5 | 22,8 | 3,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 219 | 148 | 121 | -27 |
Current financial liquidity indicator | 0.5642618536949158 | 0.5370898246765137 | 1.1196095943450928 | 0,6 |
Net dept to EBITDA | 0.3683842122554779 | -0.41816574335098267 | -1.1602778434753418 | -0,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane